Top Markets
#1 Islamic Coin Islamic Coin +151.28%
#2 Akedo Akedo +76.49%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +48.30%
#5 Cross Cross +38.19%
#6 Black Phoenix Black Phoenix +33.89%
#7 Velvet Velvet +24.60%
#8 Cap Cap +22.06%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.44%
#10 DoubleZero DoubleZero +14.35%
Coin of the day
Islamic Coin Islamic Coin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
H-CYTE, Inc. H-CYTE, Inc.

H-CYTE, Inc.

HCYT
Rangering i aksjer #39158
H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated... H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated to developing and supplying a range of treatments for individuals afflicted with persistent respiratory and pulmonary diseases. The company's core strategy involves pioneering and deploying autologous cellular therapy solutions specifically for chronic lung conditions. Additionally, H-CYTE maintains a product supply agreement with Rion, LLC, focused on advancing and distributing a biologic compound designed to combat chronic obstructive pulmonary disease (COPD). Its corporate headquarters are situated in Tampa, Florida.
Aksjekurs
$0.995
Sist synkronisert: 2023-07-07
Markedsverdi
$624.98K
Endring (1 dag)
-0.50%
Endring (1 år)
0.00%
Land
US
Handel H-CYTE, Inc. (HCYT)

Kategori

Healthcare
Aksjeprishistorikk for H-CYTE, Inc. (HCYT)
Høyeste sluttskurs: $1.00 den 2023-07-01

Laveste sluttskurs: $5.94K den 2014-12-01
Aksjeprishistorikk for H-CYTE, Inc. fra 2014 til 2026
Årlig aksjeprisytelse
År Ytelse
2023 -80.40%
2022 -87.00%
2021 141.36%
2020 -87.14%
2019 -62.16%
2018 -47.41%
2017 -55.36%
2016 21.43%
2015 -80.31%
2014 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $516.44 32.32%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $856.94 31.35%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $727.53 6.52%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $254.19 12.29%
BE